The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Abeona Therapeutics Inc(NASDAQ:ABEO) 
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated...
Website: http://www.abeonatherapeutics.com
Founded: 1974
Full Time Employees: 88
Sector: Healthcare
Industry: Biotechnology
Abeona Therapeutics Days Payable Outstanding ttm (DPO)
Abeona Therapeutics Days Receivable Outstanding ttm (DSO)
Abeona Therapeutics Days Inventory Outstanding ttm (DIO)
Abeona Therapeutics Op Cashflow Per Share ttm
Abeona Therapeutics Free Cashflow Per Share ttm
Abeona Therapeutics Cash Per Share ttm
Abeona Therapeutics P/S ratio ttm
Abeona Therapeutics (GAAP) P/E ratio ttm
Abeona Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.